Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026)

Embecta's (EMBC) quarterly Liabilities and Shareholders Equity came in at $1.0 billion in Q1 2026, down 8.11% year-on-year from $1.1 billion in Q1 2025, and down 3.23% quarter-over-quarter from $1.1 billion in Q4 2025.

Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Embecta has disclosed Liabilities and Shareholders Equity across 6 years of filings, most recently posting $1.0 billion for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $1.0 billion, down 8.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 billion (down 9.98% YoY), and the FY2025 annual result was $1.1 billion, down 15.12% from the prior year.
  • Liabilities and Shareholders Equity came in at $1.0 billion for Q1 2026 at Embecta, down from $1.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.3 billion in Q3 2024 to a low of $833.5 million in Q1 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $1.2 billion (2025), against an average of $1.1 billion.
  • Across the five-year window, Liabilities and Shareholders Equity surged 61.77% in 2022 and fell 15.12% in 2025, its largest moves.
  • Embecta's Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then increased by 1.75% to $1.2 billion in 2023, then slipped by 5.61% to $1.1 billion in 2024, then declined by 7.46% to $1.1 billion in 2025, then retreated by 3.23% to $1.0 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $1.0 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Embecta 183.23 Mn -10.17 Mn 127.80 Mn 1.03 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 1.09 Bn
Jun 30, 2025 1.16 Bn
Mar 31, 2025 1.12 Bn
Dec 31, 2024 1.15 Bn
Sep 30, 2024 1.29 Bn
Jun 30, 2024 1.27 Bn
Mar 31, 2024 1.20 Bn
Dec 31, 2023 1.22 Bn
Sep 30, 2023 1.21 Bn
Jun 30, 2023 1.25 Bn
Mar 31, 2023 1.21 Bn
Dec 31, 2022 1.20 Bn
Sep 30, 2022 1.09 Bn
Jun 30, 2022 1.05 Bn
Mar 31, 2022 833.50 Mn
Dec 31, 2021 739.90 Mn
Sep 30, 2021 788.00 Mn